{
  "cik": 1860871,
  "cik_padded": "0001860871",
  "entityName": "Tevogen Bio Holdings Inc.",
  "fiscal_years": [
    {
      "accn": "0001493152-26-014326",
      "filed": "2026-03-31",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 64439.0,
        "cash": 0.0,
        "eps_diluted": -8.08,
        "free_cash_flow": -12393016.0,
        "net_income": -26275432.0,
        "operating_cash_flow": -12328577.0,
        "operating_income": -26140515.0,
        "stockholders_equity": -8234726.0,
        "total_assets": 4382994.0,
        "total_liabilities": 12617720.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "roa_avg2y": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roa_avg2y": -6.69892687632837,
        "roe_avg2y": 3.524838163623718
      }
    },
    {
      "accn": "0001493152-26-014326",
      "filed": "2026-03-31",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 0.0,
        "eps_diluted": -3.5,
        "net_income": -13727380.0,
        "operating_cash_flow": -11998730.0,
        "operating_income": -53564488.0,
        "stockholders_equity": -6674005.0,
        "total_assets": 3461675.0,
        "total_liabilities": 10135680.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "roa_avg2y": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roa_avg2y": -3.0616945487197866,
        "roe_avg2y": 0.2715526404969068
      }
    },
    {
      "accn": "0001493152-26-014326",
      "filed": "2026-03-31",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 133000.0,
        "cash": 0.0,
        "eps_diluted": -2.44,
        "free_cash_flow": -8304118.0,
        "net_income": -60477680.0,
        "operating_cash_flow": -8171118.0,
        "operating_income": -8843025.0,
        "stockholders_equity": -94428897.0,
        "total_assets": 5505503.0,
        "total_liabilities": 99934400.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "roa_avg2y": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roa_avg2y": -0.3335375934216495,
        "roe_avg2y": 0.9421658559985389
      }
    },
    {
      "accn": "0001641172-25-002426",
      "filed": "2025-04-02",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 129186.0,
        "net_income": 4408361.0,
        "operating_cash_flow": -215395.0,
        "stockholders_equity": -33951217.0,
        "total_assets": 357138356.0,
        "total_liabilities": 15057704.0
      },
      "period_end": "2022-12-31",
      "ratio_units": {
        "roa_avg2y": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roa_avg2y": 0.012418084082536527,
        "roe_avg2y": -0.18299955461854836
      }
    },
    {
      "accn": "0001493152-24-016796",
      "filed": "2024-04-29",
      "fiscal_year": 2021,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 344581.0,
        "stockholders_equity": -14227709.0,
        "total_assets": 352852166.0,
        "total_liabilities": 15179875.0
      },
      "period_end": "2021-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001493152-26-014326",
    "filed": "2026-03-31",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2836",
  "sic_description": "Biological Products, (No Diagnostic Substances)",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001860871.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001860871.json"
  },
  "ticker": "TVGN"
}